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ABSTRACT 
Antibiotic-resistant bacteria continue to be of major health concern world-wide. Thus, it is of great interest to study the 
biological properties and determine active compounds in natural products likely to be used as new health remedies. 
Therefore, the main objective of this work is to test the antibacterial activity of royal jelly samples, defatted royal jelly 
samples and their ethyl ether extracts against bacteria capable of infecting cutaneous wounds in humans and animals, 
and to recognize major bioactive compounds by using bioassay directed identification. The microorganisms used in the 
study were Staphylococcus aureus (including Methicillin-resistant and sensitive strains), Staphylococcus epidermidis, 
Micrococcus luteus, Streptococcus uberis, Enterococcus faecalis, Pseudomonas aeruginosa, Escherichia coli, and 
Klebsiella pneumoniae. The activity of royal jelly samples to inhibit bacterial growth was assessed by using well-difus- 
sion tests. Direct bioautography was used to identify bioactivity, and uv-visible spectroscopy and gas chromatogra- 
phy-mass spectrometry were used to identify bioactive compounds. Overall, royal jelly samples showed higher growth 
inhibition activity against Gram positive bacteria as compared to Gram negative bacteria. The growth of bacterial 
strains belonging to the Enterococcus and Streptococcus genders was less affected by the presence of royal jelly than 
bacterial strains of the Staphylococcus gender did. Compounds with antibacterial activity were found in the ethyl ether 
extract of royal jelly samples. 10-hydroxy-2-decenoic acid was the major component identified in the purified fraction 
obtained by bioassay guided fractionation of the ethyl ether extract. In conclusion, bioactivity of royal jelly samples is 
mainly due to their 10-hydroxy-2-decenoic acid content. 
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1. Introduction 
The emergence of new infectious diseases, the resur- 
gence of several infections that appeared to have been 
controlled and the increase in bacterial resistance have 
created the necessity for studies directed towards the de- 
velopment of new antimicrobials [1]. Consequently, sci- 
entific efforts are being made to study and develop new 
compounds to be used beyond conventional antibiotic 
therapy. These comprise probiotic strains [2,3], waste- 
derived extracts from olive oil and wine production [4], 
peptide isolates [5], vegetal extracts [6,7], and natural 
foodstuffs such as kefir [8], honey [9,10], propolis [11] 
and royal jelly [12,13]. Despite drug discovery techno- 
logy diversification and reduced funding for natural pro- 
duct-based drug discovery, natural products from plants 
and other biological sources remain an undiminished 
source of new pharmaceuticals [14]. Thus, it is of great 
interest to study the biological properties of natural pro- 
ducts or its components likely to be used as new health 
remedies. 
Royal jelly (RJ) is a secretion produced by the hypo- 
pharyngeal and the mandibular glands in the head of the 
nurse bees. It has a thick, milky appearance, with a 
slightly acid, pungent odor and a somewhat bitter taste. 
The water content is fairly uniform, greater than 60%, 
and with a water activity (aw) above 0.92. The dry matter 
of RJ is composed of: protein (27% - 41%, including free 
amino acids), carbohydrates (approximately 30%), lipids 
(8% - 19%), trace elements and some vitamins [15]. RJ 
serves as nourishment for the honeybee larvae during *Corresponding author. 
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their first three days of life and as the sole food for the 
queen bee during its entire life span. 
Beyond its excellent nutritious properties, RJ has widely 
recognized biological actions, including vasodilative and 
hypotensive activities, disinfectant action, and antitumor, 
antihypercholesterolemic, and anti-inflammatory activi- 
ties [16]. It was also reported that RJ has antibacterial 
activity against both Gram-positive and Gram-negative 
bacteria [17]. These authors attributed the antibacterial 
activity mainly to fatty acids present in RJ, such as trans- 
10-hydroxydec-2-enoic acid, 3-hydroxydodecanoic acid, 
11-oxododecanoic acid, and 11-S-hydroxydodecanoic acid. 
They also proposed that the short extension of the pep- 
tides, their poor cytolytic and mast cell degranulating 
activities, together with their broad spectrum antibiosis, 
make them attractive models for the development of new 
antibiotic agents. 
Bacterial infections of the skin and underlying soft 
tissues are one of the most common presentations in pa- 
tients visiting emergency room clinics in both hospitals 
and office based practices [18]. Microorganisms such as 
Staphylococcus aureus, Staphylococcus epidermidis, Mi- 
crococcus luteus, Streptococcus uberis, Enterococcus fae- 
calis, Pseudomonas aeruginosa, Escherichia coli, and 
Klebsiella pneumoniae are frequently isolated from skin 
wounds in humans and animals. Methicillin-resistant and 
sensitive Staphylococcus aureus (MRSA and MSSA) are 
the main strains involved in difficult-to-treat skin and 
underlying tissue infections associated with gram-posi- 
tive bacteria [19]. Staphylococcus epidermidis infections 
are commonly acquired in the hospital as a result of con- 
tamination of surgical cuts with microorganisms from the 
patients themselves or from the hospital personnel [20]. 
Infection with Pseudomonas aeruginosa is the most se- 
rious complication in burnt patients [21,22] followed by 
infections with Klebsiella pneumoniae, Escherichia coli, 
Staphylococcus aureus and other pathogen microorgan- 
isms [21]. Thus, we considered it necessary to undertake 
studies to determine the antibacterial activity of natural 
products against these significant microorganisms. 
In this work, we identified the compound that makes 
royal jelly active against microorganisms capable of in- 
fecting cutaneous wounds. Entire RJ samples, as well as 
their defatted and lipidic extracts, were tested against 
Staphylococcus aureus, Staphylococcus epidermidis, Mi- 
crococcus luteus, Streptococcus uberis, Enterococcus fae- 
calis, Pseudomonas aeruginosa, Escherichia coli, and 
Klebsiella pneumoniae. To the best of our knowledge, 
this is the first trial of RJ and its defatted and lipidic frac- 
tions against bacteria capable of infecting cutaneous 
wounds and demonstrates their high sensibility to RJ’s 
components. A bioassay-directed fractionation of RJ’s 
active compounds showed trans-10-hydroxy-2-decenoic 
acid as the most bioactive compound. 
2. Materials and Methods 
2.1. Chemicals 
10-hydroxy-(E)2-decenoic (10-HDA) acid was purchased 
from Contech Inc., (Canada). 2,3,5-triphenyl tetrazolium 
chloride, dimethyl sulfoxide, bis(trimethylsilyl)trifluoro- 
acetamide (BSTFA) and pyridine, were purchased from 
Sigma-Aldrich (Argentina). Thin layer chromatography 
plates (silica layer, 2 - 25 μm diameter, 60 Å pore size, 
0.2 mm thick) and silica powder (60 Å, 35 - 75 μm) were 
from Fluka (USA). 
2.2. Gas Chromatographic Instrumentation 
An Agilent 6890 gas chromatograph equiped with a Fla- 
me Ionization Detector (GC-FID) and a Hewlett-Packard 
5890 equiped with a mass spectrometric detector (GC- 
MS) were used in the analysis of 10-HDA and the bioac-
tive fractions. Gas chromatographic conditions were: co- 
lumn HP5 (30 m, 0.25 mm inner diameter, 0.25 μm film 
thickness) and 250˚C injector temperature. The tem- 
perature of the oven column was changed from 70˚C to 
250˚C at 5˚C/min. Nitrogen gas at 1 mL/min was used as 
the carrier in the GC-FID analysis with a detector tem- 
perature of 250˚C. Helium gas at 1 mL/min was used as 
the carrier in the GC-MS experiment and a detector tem- 
perature of 280˚C. The EIMS spectra were obtained at 70 
eV of ionization energy. Detection was performed in full 
scan mode from 40 to 620 a.m.u. 
2.3. Royal Jelly Samples 
Royal jelly samples were obtained from four sources: 
one sample produced in southern Córdoba (Argentina) 
was acquired in the local market (named RJ R), another 
sample was provided by Estación Experimental Agrope- 
cuaria INTA Famaillá, Tucumán (Argentina) from an or- 
ganic farm (named RJ NG), another one was provided by 
a producer from La Pampa province, Argentina (named 
RJ LP) and the fourth sample was kindly provided by 
producers from the city of Corrilobo, Córdoba (Argen- 
tina) (named sample RJ C). Royal jelly samples were 
stored in sterile plastic flasks in a cold (4˚C - 8˚C) and 
dark place. The samples fulfill the requirements of the 
Código Alimentario Argentino [23]. For the agar-well 
diffusion assays, royal jelly samples were used, without 
centrifugation, undiluted and at 90%, 80%, 70%, 60%, 
50%, 40%, 30%, 20% and 10% dilutions (grams of royal 
jelly diluted with water to a final weight of 100 g). 
2.4. Royal Jelly Fractionation 
Lyophilized royal jelly samples were fractioned into ethyl 
ether-soluble compounds and defatted-royal jelly sam- 
ples by using a Soxhlet extractor. Ethyl ether was then 
evaporated under partial vacuum in a rotary evaporator  
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(30˚C) leaving an oily residue. Defatted royal jelly sam- 
ples were freed from ethyl ether under partial vacuum in 
a vacuum oven (30˚C). 
Ethyl ether soluble compounds were further separated 
by liquid-solid chromatography on silica gel using ethyl 
ether-hexane (65:35 v/v) as the mobile phase. Fractions 
of approximately 2 mL were collected in glass vials. The 
content of each glass vial was analyzed by thin layer 
chromatography (TLC) and those vials showing a TLC 
band with Rf = 0.27 were collected all together, the sol- 
vent was evaporated under partial vacuum, and the dried 
material kept in a dark vial at 4˚C - 8˚C until use.  
2.5. Sample Preparation for GC Analysis 
Approximately 0.5 mL of the 10-HDA standard or the 
bioactive band (purified as described in the previous sec- 
tion) was put into a vial of 2 mL. Then, 220 mL of pyri- 
dine and 80 mL of BSTFA were added. The reaction 
mixture was sealed and heated at 60˚C during 30 min to 
obtain the trimethylsilyl (TMS) derivatives. 
2.6. Bacterial Strains 
Reference strains of E. faecalis 1 (ATCC 29212), S. 
aureus MS 1 (ATCC 25923), S. agalactiae 1 (ATCC 
27956), S. dysgalactiae 2 (ATCC 27957), and M. luteus 
(ATCC 9341) were used. Strain of S. epidermidis was 
isolated from cow milk. Strains of S. uberis, S. agalac- 
tiae 2 and 3, and of S. dysgalactiae 2 and 3, were isolated 
from cow mastitis. Strains of E. coli and of P. aeruginosa 
1 were isolated from well water; and K. pneumoniae iso- 
lated from poultry manure were also used in this work. 
These strains were kindly donated by the Microbiology 
Laboratory of Universidad Nacional de Río Cuarto. Strains 
of S. aureus MS 2, S. aureus MR 1 and S. aureus MR 2, 
isolated from milk obtained from cows with mastitis, 
were kindly donated by the Bacteriology Laboratory of 
Universidad Federal Rural de Rio de Janeiro. Strains of E. 
faecalis 2, 3 and 4, and of E. faecium were isolated from 
skin infections in humans. The strain of P. aeruginosa 2 
was isolated from a catheter infection. All bacterial cul- 
tures but those of the Streptococcus sp. were kept in 
brain-heart infusion with 15% glycerol and maintained in 
3 mL plastic bottles at −20˚C. Streptococcus sp. strains 
were kept in skim milk yeast extract with 10% glycerol 
and maintained in 3 mL plastic bottles at −20˚C. All the 
bacterial cultures were diluted in trypticase soy broth 
(TSB) until an Optical Density (O.D.) in the range of 
0.02 - 0.04 was obtained, which corresponded to a co- 
lony count between 1 × 106 and 1 × 107 CFU/mL. 
2.7. Growth Inhibition Analysis: Agar-Well  
Diffusion Assays 
Agar-well diffusion assays were carried out with each of 
the above-mentioned bacterial strains. Two hundred mi- 
croliters of the bacterial culture were poured onto the 
Petri dish containing Mueller Hinton Agar (MHA) and 
spread with a Drigalsky spatula until the microorganisms 
were absorbed. Holes of about 5 mm diameter were 
drilled on the culture medium and 50 μL of each royal 
jelly dilution were added to each hole. Sterilized water 
was used as negative control. Plates were incubated at 
37˚C for 24 h. The diameters of the circular inhibition 
zones obtained were measured with a caliper. The ex- 
periments were repeated three times. Minimum inhibit- 
tory concentrations (MICs) were determined as the last 
royal jelly dilution which gives a measurable inhibition 
zone. 
Stock solutions of the isolated bioactive band (24 
mg/mL) and of 10-HDA (26 mg/mL) were prepared in 
50:50 DMSO-0.15% agar-agar for the study of their 
growth inhibition activity.  
2.8. Statistical Analysis 
Bacterial strains were grouped into four categories for 
the statistical analysis: Enterococcus sp., Staphylococcus 
sp., Streptococcus sp., and Gram negative bacteria. MIC 
values for each group were computed as the average of 
individual MIC values of each bacterial strains in the 
group. Statistical software R version 2.12.2 [24] was 
used for the two-tailed ANOVA computations. 
3. Results 
Table 1 shows the results of the antibacterial activity  
 
Table 1. MIC data (percent w/w.) of royal jelly samples 
against some bacteria capable of infecting cutaneous wounds 
in humans and animals. 
Bacterial strain RJ R RJ NG RJ C RJ LP 
E. faecalis 1* 80 80 60 80 
E. faecalis 2 80 90 40 100 
E. faecalis 3 N. I. 70 40 80 
E. faecalis 4 90 80 60 50 
E. faecium N. I. 70 50 50 
S. aureus MS 1* 60 20 80 50 
S. aureus MS 2 60 50 40 80 
S. aureus MR 1 70 40 60 70 
S. aureus MR 2 70 60 30 60 
S. epidermidis 80 40 50 50 
S. agalactiae 1* 90 80 50 N. I. 
S. agalactiae 2 90 50 80 100 
S. agalactiae 3 90 90 90 70 
S. dysgalactiae 1* 100 60 50 90 
S. dysgalactiae 2 80 100 90 N. I. 
S. dysgalactiae 3 80 80 90 N. I. 
S. uberis N. I. 70 60 N. I. 
M. luteus* 40 60 50 60 
E. coli 100 60 80 70 
K. pneumoniae N. I. N. I. 100 80 
P aeruginosa 1 100 N. I. 80 70 
P. aeruginosa 2 90 100 80 60 
*indicates a reference strain; N. I. indicates no inhibition. 
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studies of royal Jelly samples from different geographic 
provenance against various bacterial strains capable of 
infecting cutaneous wounds in humans and animals. The 
minimum inhibitory concentration of royal jelly samples 
(grams of royal jelly per 100 g solution) is tabulated for 
each of the bacterial strain tested in this study. 
The average MIC data obtained for each bacterial group 
and for each Royal Jelly sample geographic provenance 
were compared by two-way ANOVA. This measured the 
differences between the bacterial groups, the geographic 
provenance of the RJ samples, and their interaction. No 
significant interaction between bacterial group and RJ 
sample geographic provenance was observed (p > 0.05). 
On the other side, significant differences (p < 0.05) were 
observed in the average MIC data of the factors bacterial 
groups and those of royal jelly sample geographic prove- 
nance. The test of Tukey was then performed to compare 
average MIC data between the bacterial groups and be- 
tween RJ sample geographic provenances. Table 2 shows 
the average MIC data and standard deviations obtained in 
the growth inhibition tests with the different bacterial 
groups. Table 3 shows the results obtained (average MIC 
data and standard deviations) in the growth inhibition 
tests using RJ samples of different geographic prove- 
nance. 
Fractionation of royal jelly samples into defatted ex- 
tracts and ethyl ether-soluble substances allowed deter- 
mining which one carried the bioactive compounds. 
Ethyl ether-soluble compounds were always more active 
in inhibiting bacterial growth than defatted extracts. Thus, 
we continued with the analysis of the ethyl ether-soluble 
substances to determine the identity of bioactive com- 
pounds. 
Ethyl ether-soluble compounds were separated by thin 
layer chromatography. Five well-defined chromatographic 
bands were observed in the TLC analysis of the ethyl 
ether-soluble fraction of the different RJ samples using a 
mixture of ethyl ether:hexane (65:35 v/v). The average 
Rf values of the TLC bands were: 0.98, 0.57, 0.27, 0.18 
and 0.07. 
Direct bioautography, used for qualitative antibacterial 
activity detection, indicated that the ethyl ether-soluble 
extract has a band (Rf = 0.27) with compounds showing  
high antibacterial activity against S. aureus MS 1. Thus, 
the ether-soluble extract was submitted to flash chroma- 
tography to isolate the more active compounds. 
The isolated bioactive band was then analyzed by 
uv-visible spectroscopy, GC-FID and GC-MS. The uv- 
visible spectrum of the isolated bioactive band in metha- 
nol showed an absorbance maximum at 215 nm. A match- 
ing spectrum was obtained with a standard of 10-hydroxy 
2-decenoic acid. The GC-FID analysis of the isolated 
bioactive compound showed a major peak at 12.4 min 
and a minor peak at 11.4 min (Figure 1). The GC-FID 
analysis of the 10-HDA standard showed a peak at 12.4 
min (inset in Figure 1). These results are indicative of 
the identity of the component with a retention time of 
12.4 min. Gas chromatography with mass spectrometric 
detection can identify the component of a chromatographic 
peak. Matching MS spectra of the major chromatographic 
peaks were found in the GC-MS analysis of both the iso- 
lated bioactive band and the 10-HDA standard. The fol- 
lowing MS data (target ion m/z (Signal intensity)) 
147(100), 315(96), 73(64), 75(43), 81(37) was obtained 
in the MS analysis of the standard. The mass spectra of 
the main peak observed in the GC-MS analysis of the 
bioactive band agreed with that of the standard, when 
considering normal variability. Thus, we concluded that 
the main component of the bioactive band is 10-HDA. 
Finally, the antibacterial activities of the isolated bio- 
active band and of 10-HDA were assessed. Table 4 shows 
the results (average MIC data ± standard deviation) ob- 
tained in the growth inhibition tests analysis. 
4. Discussion 
It can be seen at first glance in Table 1 that the growth of 
all the tested bacterial strains was inhibited by some of 
the royal jelly samples studied. Overall, the royal jelly 
sample from Corrilobo (RJ C) seemed the most active 
given that it inhibited all the bacterial strains tested. The 
royal jelly sample from Norte Grande (RJ NG) inhibited 
91% of the bacterial strains tested while Regional royal 
jelly and that from La Pampa (RJ R and RJ LP) seemed 
less active given that they inhibited 82% of the bacterial 
strains tested. 
 
Table 2. Mean ± SD (%w/w) of MIC data obtained in the growth inhibition tests for the different bacterial groups. 
 Staphylococcus sp. Enterococcus sp. Streptococcus sp. Gram (-) 
MIC 53.3 ± 16.5ª 69.5 ± 18.0b 74.5 ± 16.9b 76.6 ± 16.5b 
Different superscript letters indicate statistically significant differences (p < 0.05) between bacterial groups MIC. 
 
Table 3. Mean ± SD (%w/w) of MIC data obtained in the growth inhibition tests using royal jelly samples of different prove-
nance. 
 Corrilobo Norte Grande La Pampa Regional 
MIC 59.8 ± 17.7ª 67.9 ± 21.5a,b 71.2 ± 16.5b,c 82.9 ± 12.6c 
Different superscript letters indicate statistically significant differences (p < 0.05) between bacterial groups MIC. 
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Figure 1. Gas chromatograms with Flame Ionization Detec-
tion of: (a) The bioactive band; (b) A standard of 10-HDA. 
Gas chromatographic conditions are given in the “Methods 
and Materials” section. 
 
Table 4. MIC data (average mg/mL ± SD) of the isolated 
bioactive band and of 10-HDA against some bacteria capa-
ble of infecting cutaneous wounds in humans and animals. 
Bacterial strain Isolated bioactive band 10-HDA 
E. faecalis 1* 2.0 ± 0.7 2.3 ± 0.8 
E. faecalis 2 1.6 ± 0.7 1.9 ± 0.8 
E. faecalis 3 1.6 ± 0.7 1.9 ± 0.8 
E. faecalis 4 2.0 ± 0.7 2.3 ± 0.8 
E. faecium 2.0 ± 0.7 2.3 ± 0.8 
S. aureus MS 1* 1.6 ± 0.7 1.9 ± 0.8 
S. aureus MS 2 1.6 ± 0.7 1.9 ± 0.8 
S. aureus MR 1 1.6 ± 0.7 1.9 ± 0.8 
S. aureus MR 2 2.0 ± 0.7 2.3 ± 0.8 
S. agalactiae 1* N. I. N. I. 
S. agalactiae 2 2.0 ± 0.7 2.3 ± 0.8 
S. agalactiae 3 0.8 ± 0.4 0.9 ± 0.4 
S. uberis 1.6 ± 0.7 2.3 ± 0.8 
E. coli N. I. N. I. 
K. pneumoniae N. I. N. I. 
P. aeruginosa 2 N. I. N. I. 
*indicates a reference strain. 
 
The MIC value for the various strains tested in this 
study may be considered indicative of the RJ antibacte- 
rial activity. As regards RJ R, high antibacterial activity 
was observed for Gram positive strains as can be de- 
duced from their MIC values (e.g. 40% for M. luteus). 
Similar results of antibacterial activity of RJ against M. 
luteus were informed in the literature by other authors 
[25]. Gram negative strains were less sensitive to RJ R 
given that some strains were not inhibited at all (e.g. K. 
pneumoniae), only the undiluted sample inhibited E. coli 
and P. aeruginose 1, and 90% RJ R inhibited P. aerugi- 
nose 2. These findings are in agreement with those in- 
formed in the literature by other authors [26,27]. 
Regarding RJ NG, a noticeable antibacterial activity 
was observed against most of the bacterial strains tested 
in this study. Only the growth of K. pneumonia and of P. 
aeruginosa 1 was not inhibited by RJ NG. As with RJ R, 
Gram positive bacteria seemed more sensitive to RJ NG 
than Gram negative bacterial strains did. From the latter 
group, E. coli was the most sensitive with a MIC value of 
60% and K. pneumoniae was the most resistant consi- 
dering that RJ NG did not inhibit its growth. On the other 
side, S. aureus MS 1 showed the highest sensitivity to RJ 
NG of all the bacterial strain tested in this study, with a 
MIC value of 20%. 
RJ C also produced a noticeable inhibition of bacterial 
growth. E. faecalis 2 and 3 were the most sensitive bac- 
terial strains of the Enterococcus genus, both with a MIC 
value of 40%. It is worth noting the MIC value of the S. 
aureus MR 2 bacterial strain (MIC = 30%), which may 
be interesting given that methicillin resistant bacteria can 
cause serious infections of cutaneous wounds in humans 
and animals. Methicillin resistant bacteria may also be 
resistant to other β-lactam antibiotics, to chloramphenicol, 
to tetracyclines, to macrolides, to aminoglucosides and to 
quinolones inclusive. RJ C seemed the most active RJ 
sample considering that it inhibited all the bacterial strains 
tested in this study. 
Finally, RJ LP also showed a noticeable inhibition of 
the growth of different bacterial strains, Gram positive 
bacteria seemed more sensitive than Gram negative bac- 
teria. Bacterial strains isolated from skin wounds showed 
a marked sensitivity to the presence of RJ LP. Thus, E. 
faecalis 1 and E. faecium were the most sensitive bacte- 
rial strains given that a concentration of 50% RJ LP was 
enough to inhibit bacterial growth. However, E. faecalis 
2 seemed the most resistant bacteria strain because it was 
only inhibited by pure RJ LP. 
It can be seen in Table 2 that the Staphylococcus sp. 
group was the most sensitive group to RJ samples of any 
geographic provenance, while no significant differences 
were observed among Enterococcus sp., Streptococcus 
sp. and Gram negative bacterial groups. On the other 
hand, Corrilobo and Norte Grande RJ samples were the 
most active against the growth of any bacterial group 
considering that their average MIC data were smaller 
than those obtained with RJ samples from La Pampa and 
Regional (Table 3). In a study of the substances present 
in RJ samples from different geographic provenance in 
Turkey, Stocker [25] showed that the geographic prove- 
nance of the RJ sample influenced its antibacterial ac- 
tiveity. Similar results were found in our study pointing 
to the significance of the RJ geographic provenance on 
its biological activity. 
Lercker et al. [28] identified the organic acid families 
present in royal jelly samples. By using TLC and gas  
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chromatography-mass spectrometry they showed that the 
lipid fraction of royal jelly is mainly composed of polar 
substances and that non-polar compounds are only a 
small fraction. Moreover, they showed that mono- and 
di-carboxylic fatty acids, sterols, and mono- and di-hy- 
droxyl fatty acids are the main components of the polar 
substances. 
It can be observed in Table 4 that both the isolated 
bioactive band and the 10-HDA standard showed the 
highest antibacterial activity against S. agalactiae 3. Con- 
versely, S. agalactiae 1, E. coli, K. pneumonia and P. 
aeruginosa 2 were the most resistant bacterial strains 
considering that neither the isolated active band nor the 
10-HDA standard inhibited their growth. On the other 
hand, close similarities of MIC values were observed 
between the isolated bioactive band and the 10-HDA 
standard when compared on the same bacterial strain. 
These results may also indicate that the isolated bioactive 
band is mainly composed of 10-hydroxy 2-decenoic acid, 
and that this is the compound with the highest bioactivity 
in royal jelly. 
5. Conclusion 
The growth of strains of Staphylococcus aureus (inclu- 
ding Methicillin-resistant and sensitive strains), Staphy-
lococcus epidermidis, Micrococcus luteus, Streptococcus 
uberis, Enterococcus faecalis, Pseudomonas aeruginosa, 
Escherichia coli, and Klebsiella pneumoniae was inhi- 
bited by royal jelly or by its ethyl ether extract. This find- 
ing is important because these bacteria are capable of 
infecting cutaneous wounds in humans and animals, cau- 
sing major health treatment problems in humans or sev- 
eral economic loss when milk cows are infected. High 
antibacterial activity with minimum inhibitory concen- 
trations values as low as 30% (w/w) were observed on 
Gram positive bacteria when entire royal jelly samples 
were used. Less bioactivity was observed on Gram nega- 
tive bacteria. The ethyl ether-soluble fraction of royal 
jelly showed higher bioactivity for the inhibition of bac- 
terial growth as compared with defatted royal jelly sam- 
ples. MIC values for the ethyl ether-soluble fractions 
were in the range from 0.6 to 2.4 mg/mL. Thin layer 
chromatography and bioautography-guided fractionation 
of the ethyl ether-soluble compunds allowed us to iden- 
tify the most bioactive chromatographic band, and GC- 
FID and GC-MS experiments showed that 10-hydroxy- 
2-decenoic acid was the main component of this bioac- 
tive chromatographic band. 
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